Amneal to participate at upcoming investor conferences

Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (nyse: amrx) (the “company”) today announced that the management team will attend the following investor conferences: piper sandler 34th annual healthcare conference december 1, 2022 new york, new york 41st annual j.p. morgan healthcare conference january 10, 2023 san francisco, california presentation – 2:15 pm pacific time a live webcast of the j.p. morgan healthcare conference presentation will be accessible through the investor relations section of the company's website at https://investors.amneal.com. a replay of the webcast will be posted shortly after the presentation and will be available for 90 days following the event. about amneal amneal pharmaceuticals, inc. (nyse: amrx), headquartered in bridgewater, nj, is a fully integrated essential medicines company. we make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals, primarily within the united states. the company has a diverse portfolio of over 250 products in its generics segment and is expanding across a broad range of complex products and therapeutic areas, including injectables and biosimilars. in its specialty segment, amneal has a growing portfolio of branded pharmaceutical products focused primarily on central nervous system and endocrine disorders, with a pipeline focused on unmet needs. through its avkare segment, the company is a distributor of pharmaceuticals and other products for the u.s. federal government, retail, and institutional markets. for more, please visit www.amneal.com.
AMRX Ratings Summary
AMRX Quant Ranking